
Inari Medical (NARI) Earnings Dates & Reports
Inari Medical (NARI) Most Recent Earnings
Report Date
Period EndingQ3 2024
Est. EPS-$0.11
Actual EPS-$0.20
EarningsMiss
Inari Medical (NARI) Earnings
View the latest Inari Medical (NARI) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Inari Medical (NARI)
Order type
Buy in
Order amount
Est. shares
0 shares
Inari Medical (NARI) Earnings per Share (EPS) History
Signup for full accessBrowse free
Inari Medical (NARI) Latest Earnings
The value each NARI share was expected to gain vs. the value each share gained.
Inari Medical (NARI) reported its most recent earnings on for Q3 2024, posting earnings per share (EPS) of -$0.20. This exceeded analysts' expectations of -$0.11 by 81.82%, marking a Miss.
For comparison, Inari Medical reported EPS of $0.05 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Inari Medical (NARI) Earnings History
Inari Medical (NARI) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Inari Medical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Inari Medical (NARI) Earnings FAQs
Inari Medical (NARI) last reported earnings on Oct 28, 2024 for Q3 2024, posting an EPS of -$0.20, which Miss the estimate of -$0.11 by 81.82%.
For Q3 2024, Inari Medical (NARI) reported an EPS of -$0.20, missing analysts' estimate of -$0.11 by 81.82%.
For Q3 2024, Inari Medical (NARI) Miss expectations with an actual EPS of -$0.20 vs. an estimated EPS of -$0.11.
Following the last earnings report on Oct 28, 2024, Inari Medical (NARI)'s stock price moved — from — to —.
The next Inari Medical (NARI) earnings call is scheduled for Oct. 28, 2024, where executives will discuss financial results and outlook.